Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Find out How Index Funds are Traded, Priced & Potential Issues You May Face

Mutualfunds logo

SHSCX BlackRock Health Sciences Opps Inv C

  • Fund
  • SHSCX
  • Price as of: Jul 21, 2017
  • $48.24
  • + $0.02
  • + 0.04%
  • Category
  • Health & Biotech Equities

SHSCX - Profile

Vitals

  • YTD Return 21.5%
  • 3 Yr Annualized Return 5.1%
  • 5 Yr Annualized Return 10.4%
  • Net Assets $5.83 B
  • Holdings in Top 10 36.7%

52 WEEK LOW AND HIGH

$48.24
$39.17
$48.24

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.90%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 50.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$100

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 21.5%
  • 3 Yr Annualized Total Return 7.9%
  • 5 Yr Annualized Total Return 18.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.75%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name BlackRock
  • Inception Date Oct 16, 2000
  • Shares Outstanding N/A
  • Share Class C
  • Currency USD
  • Domiciled Country United States
  • Manager Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.

SHSCX - Performance

Return Ranking - Trailing

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 21.5% -14.9% 32.3% 53.57% 3
1 Yr 10.0% -14.8% 43.3% 49.55% 3
3 Yr 5.1% * -7.5% 18.2% 30.56% 2
5 Yr 10.4% * 9.3% 21.8% 51.49% 3
10 Yr 6.1% * 6.1% 15.7% 50.57% 3

* Annualized


Return Ranking - Calendar

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -9.2% -29.8% 2.6% 21.82% 2
2015 -3.3% -20.4% 14.5% 58.18% 3
2014 19.5% -5.8% 33.7% 31.82% 2
2013 29.5% -2.6% 65.2% 71.56% 4
2012 9.6% -5.3% 36.5% 70.87% 4

Total Return Ranking - Trailing

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 21.5% -14.9% 32.3% 54.05% 3
1 Yr 10.0% -18.3% 41.2% 50.91% 3
3 Yr 7.9% * -14.2% 18.2% 62.96% 4
5 Yr 18.9% * 9.1% 21.8% 69.31% 4
10 Yr 14.7% * 6.1% 15.7% 51.19% 3

* Annualized


Total Return Ranking - Calendar

Period SHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -9.2% -25.1% 6.3% 23.85% 2
2015 -3.3% -16.6% 39.1% 88.99% 5
2014 30.5% -5.8% 100.0% 62.39% 4
2013 56.0% -5.1% 398.7% 84.26% 5
2012 26.9% -2.6% 475.8% 81.00% 5

NAV & Total Return History

SHSCX - Holdings

Filings data as of: May 31, 2017

Concentration Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Net Assets 5.83 B 20.8 M 48.3 B 5.36% 1
Number of Holdings 101 32 365 9.82% 2
Net Assets in Top 10 2.05 B 9.25 M 20.1 B 6.25% 1
Weighting of Top 10 36.7% 19.5% 71.8% 27.68% 4

Top 10 Holdings

  1. UnitedHealth Group Inc 7.58%
  2. Medtronic PLC 5.18%
  3. Boston Scientific Corp 3.14%
  4. Amgen Inc 3.11%
  5. Celgene Corp 3.65%
  6. Humana Inc 2.87%
  7. Allergan PLC 2.62%
  8. Stryker Corp 3.08%
  9. Baxter International Inc 2.84%
  10. Johnson & Johnson 2.58%

Asset Allocation

Weighting Category Low Category High SHSCX % Rank Quintile
Stocks
96.20% 85.65% 102.85% 26.79% 4
Cash
2.99% -0.06% 14.35% 8.04% 2
Other
0.80% -11.71% 7.50% 8.04% 2
Preferred Stocks
0.00% 0.00% 0.71% 5.36% 2
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 1
Bonds
0.00% 0.00% 5.97% 4.46% 2

Stock Sector Breakdown

Weighting Category Low Category High SHSCX % Rank Quintile
Healthcare
95.37% 11.52% 99.64% 16.07% 3
Consumer Cyclical
0.44% 0.00% 5.10% 3.57% 1
Technology
0.40% 0.00% 64.38% 24.11% 4
Utilities
0.00% 0.00% 1.11% 1.79% 1
Real Estate
0.00% 0.00% 1.50% 2.68% 1
Industrials
0.00% 0.00% 8.05% 10.71% 2
Financial Services
0.00% 0.00% 5.16% 6.25% 2
Energy
0.00% 0.00% 0.00% 0.89% 1
Communication Services
0.00% 0.00% 0.00% 0.89% 1
Consumer Defense
0.00% 0.00% 2.14% 13.39% 3
Basic Materials
0.00% 0.00% 1.96% 4.46% 2

Stock Geographic Breakdown

Weighting Category Low Category High SHSCX % Rank Quintile
US
90.78% 59.77% 99.64% 12.50% 2
Non US
5.42% 0.00% 40.28% 23.21% 4

SHSCX - Expenses

Operational Fees

SHSCX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.90% 0.10% 4.31% 18.75% 4
Management Fee 0.68% 0.09% 1.25% 10.71% 2
12b-1 Fee 1.00% 0.00% 1.00% 1.27% 4
Administrative Fee 0.06% 0.01% 0.40% 12.31% 2

Sales Fees

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load 1.00% 1.00% 5.00% 12.50% 1

Trading Fees

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SHSCX Fees (% of AUM) Category Low Category High SHSCX Rank Quintile
Turnover 50.00% 0.00% 699.00% 14.29% 4

SHSCX - Distributions

Dividend Yield Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

SHSCX Category Low Category High Category Mode
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

SHSCX Category Low Category High SHSCX % Rank Quintile
Net Income Ratio -0.75% -2.22% 1.40% 50.89% 4

Capital Gain Distribution Analysis

SHSCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

SHSCX - Managers

Erin Xie

Manager

Start Date

Jul 31, 2003

Tenure

13.93

Tenure Rank

5.3%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.


Tenure Analysis

Category Low

0.0

Category High

19.8

Category Average

8.78

Category Mode

2.5